Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |